Back to SO SOROS FUND MANAGEMENT LLC
ALXNShowing 0 of 2 quarters
Position history for SOSOROS FUND MANAGEMENT LLC's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Soros Fund Management held 500,001 shares of ALXN (Alexion Pharmaceuticals), worth $91.9M. ALXN was 1.5% of Soros Fund Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP